Type your tag names separated by a space and hit enter

Apixaban increases bleeding with no benefit in high-risk patients with ACS

Apixaban increases bleeding with no benefit in high-risk patients with ACS is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

Slawson, David C., et al., editors. "Apixaban Increases Bleeding With No Benefit in High-risk Patients With ACS." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS.
Apixaban increases bleeding with no benefit in high-risk patients with ACS. In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS. Accessed March 24, 2019.
Apixaban increases bleeding with no benefit in high-risk patients with ACS. (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS
Apixaban Increases Bleeding With No Benefit in High-risk Patients With ACS [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Apixaban increases bleeding with no benefit in high-risk patients with ACS ID - 427359 ED - Slawson,David C, ED - Shaughnessy,Allen F, ED - Ebell,Mark H, ED - Barry,Henry, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427359/all/Apixaban_increases_bleeding_with_no_benefit_in_high_risk_patients_with_ACS PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -